Back to companies
Coherus Oncology, Inc.
CHRSUSNASDAQPharmaceuticals & HealthcareCoherus Oncology, Inc.
Revenue
$42.2mn
YoY -84.2%
Operating income
-$181.1mn
FY2025
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API